Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation

V2, Crosslink

🧫

Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-amyloid-

🧫 Experiment Protocol Clinicalproposed

SUMMARY

# Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation ## Background and Rationale The amyloid cascade hypothesis has dominated Alzheimer's disease (AD) research for over three decades, positing that the accumulation of amyloid-beta (Aβ) peptides, particularly Aβ42, initiates a pathological cascade leading to tau hyperphosphorylation, neuroinflammation, synaptic dysfunction, and ultimately neurodegeneration. This mechanistic framework has guided the development of numerous

METHODOLOGY NOTES

Phase 1 (Months 0-3): Recruit 240 mild cognitive impairment/early AD patients, stratified by APOE4 status and CSF p-tau181 levels. Collect baseline measurements including 18F-flortaucipir PET, 11C-PIB amyloid PET, structural MRI with DTI, plasma biomarkers (p-tau217, NfL, GFAP), and comprehensive neuropsychological testing (CDR-SB, ADAS-Cog13, MMSE). Phase 2 (Months 3-21): Randomize patients 2:1 to lecanemab (10mg/kg biweekly) versus placebo. Perform monthly cognitive assessments and plasma biomarker sampling. Conduct PET imaging at months 6, 12, and 18. Use advanced MRI sequences (7T when available) to measure microglial activation (TSPO-PET), synaptic density (11C-UCB-J PET), and white matter integrity. Phase 3 (Months 18-24): Primary endpoint assessment with repeat comprehensive testing battery. Perform single-cell RNA sequencing on CSF cells to characterize microglial phenotypes. Correlate amyloid clearance rates with tau propagation patterns using network-based tau-PET analysis. P

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.901843Z'}
summary	# Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation ## Background and Rationale The amyloid cascade hypothesis has dominated Alzheimer's disease (AD) research for over three
entities	{'genes': ['CENTIRON'], 'diseases': ["Alzheimer's Disease"]}
model_system	human
_schema_version	1
experiment_type	clinical
primary_outcome	Validate Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation
methodology_notes	Phase 1 (Months 0-3): Recruit 240 mild cognitive impairment/early AD patients, stratified by APOE4 status and CSF p-tau181 levels. Collect baseline measurements including 18F-flortaucipir PET, 11C-PIB
replication_status	single_study
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.901848', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

619

Outgoing

563

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investigation

derives from (16)

supports (234)

💬 Discussion